Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Peerj
|
October 17, 2022
Effectiveness of a community-based peer support service among persons suffering severe mental illness in China
Yunge Fan, Ning Ma, Aili Ouyang, et al.
Cancer Chemotherapy and Pharmacology
|
October 13, 2010
Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial
Binghe Xu, Zefei Jiang, Zhimin Shao, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
May 16, 2024
Efficacy and safety of inetetamab in combination with chemotherapy as first-line treatment of HER2-positive metastatic breast cancer: a subgroup analysis in the HOPES study
Tao Wang, Pin Zhang, Lijun Di, et al.
Renal Failure
|
April 25, 2025
Development and external validation of a machine learning model for cardiac valve calcification early screening in dialysis patients: a multicenter study
Xiaoxu Wang, Yinfang Li, Zixin Cao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
June 23, 2021
Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis
Huiping Li, Cuizhi Geng, Hongmei Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2013
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer
Zhongzhen Guan, Binghe Xu, Michelle L DeSilvio, et al.
Oncoimmunology
|
July 29, 2016
Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization
Fan Zhang, Junlan Yang, Huafei Li, et al.
The Lancet. Oncology
|
February 18, 2017
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial
Pin Zhang, Tao Sun, Qingyuan Zhang, et al.
Therapeutic Advances in Medical Oncology
|
November 4, 2022
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer
Min Yan, Peng Yuan, Quchang Ouyang, et al.
Cancer
|
July 26, 2020
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018)
Binghe Xu, Xichun Hu, Jifeng Feng, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Peerj
|
October 17, 2022
Effectiveness of a community-based peer support service among persons suffering severe mental illness in China
Yunge Fan, Ning Ma, Aili Ouyang, et al.
Cancer Chemotherapy and Pharmacology
|
October 13, 2010
Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial
Binghe Xu, Zefei Jiang, Zhimin Shao, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
May 16, 2024
Efficacy and safety of inetetamab in combination with chemotherapy as first-line treatment of HER2-positive metastatic breast cancer: a subgroup analysis in the HOPES study
Tao Wang, Pin Zhang, Lijun Di, et al.
Renal Failure
|
April 25, 2025
Development and external validation of a machine learning model for cardiac valve calcification early screening in dialysis patients: a multicenter study
Xiaoxu Wang, Yinfang Li, Zixin Cao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
June 23, 2021
Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis
Huiping Li, Cuizhi Geng, Hongmei Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2013
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer
Zhongzhen Guan, Binghe Xu, Michelle L DeSilvio, et al.
Oncoimmunology
|
July 29, 2016
Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization
Fan Zhang, Junlan Yang, Huafei Li, et al.
The Lancet. Oncology
|
February 18, 2017
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial
Pin Zhang, Tao Sun, Qingyuan Zhang, et al.
Therapeutic Advances in Medical Oncology
|
November 4, 2022
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer
Min Yan, Peng Yuan, Quchang Ouyang, et al.
Cancer
|
July 26, 2020
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018)
Binghe Xu, Xichun Hu, Jifeng Feng, et al.
Page
of 7